Ryan Cappelli
@Prosight Management, Lp
Latest period2024 - Q3ReportedManaged Assets$406.357MTotal holdings45
Assets growth rate21.46%Assets growth rate (2-Q avg)7.27%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Prosight Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.
Assets under management
The assets under management (AUM) of Prosight Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 406.357M in assets, with a quarterly growth rate of 21.46% and a 2-quarter average growth rate of 7.27%. The portfolio is managed by Ryan Cappelli, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ADCTAdc Therapeutics Sa
| 7.47% | $30.354M 9.636M shares@ $3.16 avg price | Increased 0.7% |
GLPGGalapagos Nv
| 7.29% | $29.62M 1.029M shares@ $28.8 avg price | Decreased -23.78% |
BBIOBridgebio Pharma Inc
| 6.81% | $27.67M 1.087M shares@ $25.47 avg price | Increased 35.86% |
ABCLAbcellera Biologics Inc
| 5.81% | $23.607M 9.08M shares@ $2.6 avg price | Increased 285.94% |
MGTXMeiragtx Hldgs Plc
| 5.03% | $20.435M 4.901M shares@ $4.18 avg price | Increased 12.59% |
ROIVRoivant Sciences Ltd
| 4.89% | $19.866M 1.722M shares@ $11.54 avg price | Decreased -13.92% |
STTKShattuck Labs Inc
| 4.88% | $19.819M 5.679M shares@ $3.5 avg price | Increased 21.61% |
MIRMMirum Pharmaceuticals Inc
| 4.48% | $18.167M 465,825 shares@ $39.0 avg price | Increased 47.98% |
ZBHZimmer Biomet Holdings Inc
| 4.4% | $17.877M 165,602 shares@ $107.96 avg price | Decreased -2.58% |
MCKMckesson Corp
| 4.36% | $17.711M 35,822 shares@ $494.42 avg price | New Position |